YUKON DENALI 以其霸气的外观、强大的性能和极致的奢华，成为了好莱坞明星们的传奇座驾。它不仅是一款交通工具，更是一种身份与品味的象征。无论是在繁华的都市街头，还是在星光熠熠的红毯上，YUKON DENALI ...

根据提交给美国证券交易委员会的文件显示，Denali Therapeutics Inc. (NASDAQ:DNLI)的首席医疗官Carole Ho最近出售了公司的普通股。1月6日和7日，Ho总共出售了15,162股，获得308,290美元。售价在每股20.22美元至20.81美元之间。根据 InvestingPro ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

根据美国证券交易委员会的一份文件显示，市值30.5亿美元、财务健康指标强劲的生物科技公司Denali Therapeutics Inc. (NASDAQ:DNLI)的董事Steve Krognes最近出售了该公司的股票。该公司保持稳健的流动性状况，流动比率为9.98倍，根据 InvestingPro ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Denali's DNL343 missed efficacy goals in the HEALEY ALS trial but was well-tolerated. Analysts await detailed biomarker data ...

Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tividenofusp alfa (DNL310) for the treatment ...